Literature DB >> 8657428

Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat.

Michael H Ossipov1, Carl J Kovelowski, Michael L Nichols, Victor J Hruby, Frank Porreca.   

Abstract

Supraspinally mediated antinociception has been clearly established for agonists acting via both micro- and delta-opioid receptors. The present experiments were undertaken to further characterize the role of supraspinal opioid delta receptors in the mediation of antinociception in rats and to examine the possible role of putative delta1- and delta2-opioid receptors in the antinociceptive effect. Cannulae directed at the right lateral ventricle, the periaqueductal gray (PAG), or the medullary reticular formation (MRF) were implanted in adult male, Sprague-Dawley rats for the microinjection of [D-Ala2,Glu4]deltorphin (delta2 agonist), [D-Pen2,D-Pen5]enkephalin (DPDPE, delta1 agonist), [D-Ser2,Leu5,Thr6]enkephalin (DSLET, mixed delta/micro agonist) or morphine (reference micro-opioid). Pretreatments (24 h prior to agonist microinjection) were made with the putative delta1 and delta2 antagonists, [D-Ala2,Leu5,Cys6]enkephalin (DALCE) and [D-Ala2,Cys4]deltorphin (Cys-DELT) and antinociception was measured in the 55 degrees C hot plate (HP) and 52 degrees C and 55 degrees C (low and high intensity) warm-water tail-flick (TF) tests. Data were converted to percent maximal possible effect (%MPE). Intracerebroventricular (i.c.v.) administration of DPDPE produced less than a 50%MPE in the HP test whereas [d-Ala2,Glu4]deltorphin produced Cys-DELT sensitive antinociception of up to 92% MPE. Neither i.c.v. agonist was effective in the TF assays, and both agonists were without effect in the PAG. [D-Ala2,Glu4]deltorphin microinjected into the MRF produced Cys-DELT sensitive antinociception of 60 and 47% MPE in the HP and low-intensity TF tests, respectively, but was not effective in the 55 degrees C TF test; DPDPE did not produce antinociception when microinjected at this site. Microinjection of DSLET in the MRF produced significant antinociception in all three assays. Morphine produced antinociception following i.c.v. administration or microinjection into the PAG in all tests. Microinjection of morphine into the MRF produced antinociception in the HP and 52 degrees C, but not 55 degrees C, TF tests. Morphine anticociception was not antagonized by either DALCE or Cys-DELT. These data demonstrate that supraspinal delta-opioid receptors can be activated to elicit antinociception in the rat and that opioid delta2 receptors predominate in this effect. Further, these effects may occur predominately via inhibition of supraspinally organized behavior without activation of descending systems such as those mediating the TF response in the rat.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8657428     DOI: 10.1016/0304-3959(94)00231-3

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  19 in total

1.  Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.

Authors:  C Wahlestedt; P Salmi; L Good; J Kela; T Johnsson; T Hökfelt; C Broberger; F Porreca; J Lai; K Ren; M Ossipov; A Koshkin; N Jakobsen; J Skouv; H Oerum; M H Jacobsen; J Wengel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  How to design an opioid drug that causes reduced tolerance and dependence.

Authors:  Amy Chang Berger; Jennifer L Whistler
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

3.  Antinociceptive and neurochemical effects of a single dose of IB-MECA in chronic pain rat models.

Authors:  Stefania Giotti Cioato; Liciane Fernandes Medeiros; Bettega Costa Lopes; Andressa de Souza; Helouise Richardt Medeiros; José Antônio Fagundes Assumpção; Wolnei Caumo; Rafael Roesler; Iraci L S Torres
Journal:  Purinergic Signal       Date:  2020-11-08       Impact factor: 3.765

Review 4.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 5.  Endogenous opioid peptides in the descending pain modulatory circuit.

Authors:  Elena E Bagley; Susan L Ingram
Journal:  Neuropharmacology       Date:  2020-05-15       Impact factor: 5.250

6.  Central noradrenergic activity affects analgesic effect of Neuropeptide S.

Authors:  Kei Jinushi; Tetsuya Kushikata; Takashi Kudo; Girolamo Calo; Remo Guerrini; Kazuyoshi Hirota
Journal:  J Anesth       Date:  2017-11-11       Impact factor: 2.078

7.  Opioid presynaptic disinhibition of the midbrain periaqueductal grey descending analgesic pathway.

Authors:  Benjamin K Lau; Bryony L Winters; Christopher W Vaughan
Journal:  Br J Pharmacol       Date:  2020-02-15       Impact factor: 8.739

8.  Opioid receptor internalization contributes to dermorphin-mediated antinociception.

Authors:  T A Macey; S L Ingram; E N Bobeck; D M Hegarty; S A Aicher; S Arttamangkul; M M Morgan
Journal:  Neuroscience       Date:  2010-04-13       Impact factor: 3.590

9.  Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation.

Authors:  G L Fraser; G A Gaudreau; P B Clarke; D P Ménard; M N Perkins
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

10.  Tuned-Affinity Bivalent Ligands for the Characterization of Opioid Receptor Heteromers.

Authors:  Jessica H Harvey; Darcie H Long; Pamela M England; Jennifer L Whistler
Journal:  ACS Med Chem Lett       Date:  2012-08-09       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.